| Serial Number | 79364021 |
| Word Mark | SEPSIA THERAPEUTICS |
| Filing Date | Wednesday, October 26, 2022 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, September 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 3, 2024 |
| Description of Mark | The mark consists of the word "SEPSIA" in stylized capital letters, where the term "SEP" is in blue, and the term "SIA" is transparent appearing on a blue background in the form of a halved oblong shape. Below in stylized lowercase letters in blue is the wording "THERAPEUTICS". The color white represents background and is not a part of the mark. |
| Goods and Services | Pharmaceutical products namely, pharmaceutical preparations for human and veterinary use for the treatment of infectious diseases, inflammatory conditions, sepsis, advanced cell therapies and immunotherapy; biological preparations for medical and veterinary use, namely, biological preparations for the treatment of infectious diseases; pharmaceutical, biological and veterinary preparations for the treatment of infectious diseases and related inflammatory processes, for the treatment of sepsis and for advanced cell therapies and immunotherapy; pharmaceutical preparations containing nucleic acids and proteins and active peptides for medical and veterinary use, namely, pharmaceutical preparations containing nucleic acids and proteins and active peptides for the treatment of infectious diseases and related inflammatory processes, for the treatment of sepsis and for advanced cell therapies and immunotherapy |
| Indication of Colors claimed | The color(s) blue is/are claimed as a feature of the mark. |
| Translation of Words in Mark | The English translation of "SEPSIA" in the mark is "Sepsis". |
| NOT AVAILABLE | "SEPSIA THERAPEUTICS" |
| Goods and Services | Medical machines for dialysis, hemoperfusion and hemoadsorption; medical devices for blood purification, namely, hemoperfusion machines; medical adsorption devices and polymeric adsorption materials for the removal of materials from the blood or from blood fractions and kits primarily containing said testing devices for the identification of bacteria for medical use; electrical instruments for medical use in blood diagnostic analysis; assay instruments for medical diagnostic use in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; medical diagnostic testing instruments for use in immunoassay procedures; diagnostic apparatus for medical use in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; medical diagnostic testing apparatus for use in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for immunoassay procedures; apparatus and instruments for diagnostic testing for medical purposes in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; apparatus and instruments for veterinary diagnosis in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; medical diagnostic instruments for diagnosis in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids for infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; dialysis apparatus, namely, dialysis and hemofiltration machines; dialysis machines for veterinary use, namely, dialysis and hemofiltration machines; dialysis machines for medical use |
| Goods and Services | Scientific and technological services, as well as associated research and design services, namely, scientific research and development in the fields of biochemicals, pharmacy, medicine and veterinary medicine; industrial analysis services related to biology, biochemistry, chemistry, pharmacy, medicine and veterinary medicine, industrial research in the fields of biology, biochemistry, chemistry, pharmacy, medicine and veterinary medicine; scientific research services related to biology, biochemistry, chemistry, pharmacy, medicine and veterinary medicine; scientific research services related to the treatment of infectious diseases and related inflammatory processes, sepsis and advanced cell therapies and immunotherapy; scientific research services related to peptides and proteins for pharmaceutical, medical and veterinary use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 3, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 3, 2023 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 3, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SEPSIA THERAPEUTICS, S.L. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Party Name | SEPSIA THERAPEUTICS, S.L. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Event Date | Event Description |
| Thursday, August 10, 2023 | ASSIGNED TO EXAMINER |
| Thursday, March 2, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 7, 2023 | APPLICATION FILING RECEIPT MAILED |
| Friday, August 18, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, August 19, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, September 11, 2023 | REFUSAL PROCESSED BY MPU |
| Monday, September 11, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, October 4, 2023 | REFUSAL PROCESSED BY IB |
| Wednesday, January 24, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 25, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, February 25, 2024 | NON-FINAL ACTION E-MAILED |
| Sunday, February 25, 2024 | NON-FINAL ACTION WRITTEN |
| Sunday, February 25, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, July 24, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 24, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 25, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, July 25, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, July 25, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, July 25, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 25, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 31, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, July 31, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, August 14, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 3, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Saturday, August 17, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, March 26, 2024 | REFUSAL PROCESSED BY IB |